Tag: Gilead Sciences Inc

Remdesivir Coronavirus Trial: Federal Scientists Finally Publish Data

Nearly a month after federal scientists claimed that an experimental drug had helped patients severely ill with the coronavirus, the research has been published. The drug, remdesivir, was quickly authorized by the Food and Drug Administration for treatment of coronavirus patients, and hospitals rushed to obtain supplies. But until now, researchers and physicians had not […]

Read More

How Upbeat Vaccine News Fueled a Stock Surge, and an Uproar

When the biotech company Moderna announced early on Monday morning positive results from a small, preliminary trial of its coronavirus vaccine, the company’s chief medical officer described the news as a “triumphant day for us.” Moderna’s stock price jumped as much as 30 percent. Its announcement helped lift the stock market and was widely reported […]

Read More

Haphazard Rollout of Coronavirus Drug Frustrates Doctors

When the Food and Drug Administration granted an emergency approval last week for an antiviral drug, remdesivir, to treat hospitalized coronavirus patients, many doctors were overjoyed. The drug is the first shown to be even mildly effective against the virus. But bafflement soon followed as doctors and hospitals tried to obtain the drug. Small community […]

Read More

How Remdesivir, New Hope for Covid-19 Patients, Was Resurrected

Remdesivir, an antiviral drug designed to treat both hepatitis and a common respiratory virus, seemed fated to join thousands of other failed medications after proving useless against those diseases. The drug was consigned to the pharmaceutical scrap heap, all but forgotten by the scientists who once championed it. But on Friday, the Food and Drug […]

Read More

Gilead Claims ‘Positive Data’ to Come From N.I.H. Trial of Remdesivir

Gilead Sciences on Wednesday announced that the company “is aware of positive data” from a federal trial of its experimental coronavirus drug, remdesivir, even as a new study reported that the drug offered no benefit to severely ill patients in China. Neither Gilead nor officials at the National Institute of Allergy and Infectious Diseases, sponsor […]

Read More

The Story of Remdesivir

Diana Brainard is nowhere near close to celebrating. Dr. Brainard is the head of antiviral clinical research at Gilead Sciences, the Bay Area biotech giant whose drug portfolio includes the antiviral medicine remdesivir. On Thursday, Stat, the superb medical-news website, reported some of the leaked results of a pair of Phase 3 clinical trials of […]

Read More

Pharmaceutical Profits and Fighting Corona Are Not Incompatible

The rapid spread of the coronavirus has revived a decades-old debate over pharmaceutical policy, with both sides doubling down on long-held views. Advocates for broader drug access insist that pharmaceutical companies must not be allowed to reap large profits from Covid-19 vaccines and treatments. Free-market true believers — including officials in the Trump administration — […]

Read More

Gilead Withdraws Request for Special Orphan Status on Experimental Coronavirus Treatment

Bowing to criticism that it was exploiting the coronavirus pandemic, the drugmaker Gilead said on Wednesday that it would no longer seek orphan-drug status for remdesivir, an experimental drug that is being tested as a possible treatment. The Food and Drug Administration had only granted the special designation on Monday — which gives drug companies […]

Read More

Coronavirus Patients in Limbo as Gilead Suspends Emergency Drug Access

Overwhelmed by demand for an experimental treatment for coronavirus, the drug maker Gilead abruptly shut down its emergency access program, leaving doctors and families scrambling for answers. The company said it was setting up a broader access program that could try to help more people, but some said the transition is delaying remedies for very […]

Read More

With Minimal Evidence, Trump Asks F.D.A. to Study Malaria Drugs for Coronavirus

President Trump on Thursday exaggerated the potential of drugs available to treat the new coronavirus, including an experimental antiviral treatment and decades-old malaria remedies that hint of promise but so far show limited evidence of healing the sick. No drug has been approved to treat the new coronavirus, and doctors around the world have been […]

Read More

China Begins Testing an Antiviral Drug in Coronavirus Patients

China is forging ahead in the search for treatments for people sickened by the new coronavirus that has infected more than 28,000 people in a countrywide epidemic, killed more than 500 and seeded smaller outbreaks in 24 other nations. The need is urgent: There are no approved treatments for illnesses caused by coronaviruses. On Thursday, […]

Read More